These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15476572)

  • 1. Optimal antithrombotic management of anticoagulated patients with a history of myocardial infarction.
    Gibbs WJ; Fugate SE; Vesta KS
    Cardiol Rev; 2004; 12(6):327-33. PubMed ID: 15476572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of antithrombotic agents in acute myocardial infarction.
    Khalilullah M; Sathyamurthy I
    J Assoc Physicians India; 1981 May; 29(5):351-7. PubMed ID: 7028713
    [No Abstract]   [Full Text] [Related]  

  • 3. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
    Gianetti J; Gensini G; De Caterina R
    Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is optimal antithrombotic therapy after myocardial infarction well defined?
    McAnulty JH
    Curr Cardiol Rep; 2001 Jan; 3(1):53-5. PubMed ID: 11139799
    [No Abstract]   [Full Text] [Related]  

  • 6. The evolution of antithrombotic treatments in myocardial infarction.
    de Nicola P
    New Istanbul Contrib Clin Sci; 1972 Dec; 10(3):142-6. PubMed ID: 4670447
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombotic therapy after myocardial infarction.
    Becker RC
    N Engl J Med; 2002 Sep; 347(13):1019-22. PubMed ID: 12324559
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombosis and antithrombotic agents in peripheral artery disease].
    Emmerich J
    Arch Mal Coeur Vaiss; 2002 Nov; 95 Spec No 7():59-62. PubMed ID: 12500607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The antithrombotic action of oral anticoagulants, acetylsalicylic acid (Aspirin) and dipyridamole (Persantin)].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1984 Oct; 128(43):2047-9. PubMed ID: 6390223
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current problems of antithrombotic therapy].
    Liusov VA; Belousov IuB
    Kardiologiia; 1981 Aug; 21(8):5-17. PubMed ID: 7026869
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic stewardship: a multidisciplinary team approach towards improving antithrombotic therapy outcomes during and after hospitalisation: a study protocol.
    Dreijer AR; Kruip MJ; Diepstraten J; Polinder S; Brouwer R; Leebeek FW; Vulto AG; van den Bemt PM
    BMJ Open; 2016 Dec; 6(12):e011537. PubMed ID: 27998897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    MacLean S; Mulla S; Akl EA; Jankowski M; Vandvik PO; Ebrahim S; McLeod S; Bhatnagar N; Guyatt GH
    Chest; 2012 Feb; 141(2 Suppl):e1S-e23S. PubMed ID: 22315262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New agents and challenges in the antithrombotic management of arterial diseases].
    Udvardy M; Rák K
    Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of antithrombotic drugs in artery disease.
    Gallus AS
    Clin Haematol; 1986 May; 15(2):509-59. PubMed ID: 3524934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of antithrombotic agents after myocardial infarction].
    Castaigne A; Albo C; Verschuren P; Perchet H; Pham I; Saal JP
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1703-8. PubMed ID: 1304143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives].
    Scardi S; Mazzone C
    Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithrombotic therapy of ischemic heart disease].
    Liusov VA; Belousov IuB
    Kardiologiia; 1974 Jul; 14(7):113-21. PubMed ID: 4431131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.